Thoracic Aortic Aneurysm
An abnormal dilation of the thoracic aorta exceeding 1.5 times its normal diameter, predisposing to dissection or rupture.
Thoracic Aortic Aneurysm (TAA)
Definition
An aneurysm is a pathological, localized, and permanent dilatation of a blood vessel by ≥50% of its normal diameter [1][2]. Let's break that definition down:
- Pathological: This isn't a normal variant — it represents disease.
- Localized: It affects a segment, not the entire vessel.
- Permanent: It doesn't go away on its own (unlike vasospasm-related transient dilatation).
- ≥50% of normal diameter: The normal thoracic aorta varies by segment (see Anatomy below), but as a rough guide the ascending aorta is ~3.0–3.5 cm and the descending thoracic aorta is ~2.0–2.5 cm. So a thoracic aortic aneurysm (TAA) is generally defined as dilatation of any segment of the thoracic aorta to >50% above its expected normal diameter — typically >4.5 cm for the ascending aorta or >3.5 cm for the descending thoracic aorta, though sex- and body-size-adjusted nomograms are increasingly used [3].
An aortic ectasia refers to dilatation of < 50% of normal diameter — i.e., the aorta is a bit bigger than it should be, but doesn't meet the threshold for aneurysm [2].
| Feature | True Aneurysm | False (Pseudo-) Aneurysm |
|---|---|---|
| Wall composition | All 3 layers intact (intima, media, adventitia) — though attenuated | Wall formed by extravascular connective tissue only (essentially a contained rupture / pulsating haematoma) |
| Common causes | Degenerative, connective tissue disease, atherosclerotic | Post-traumatic (e.g., deceleration injury at isthmus), post-surgical (anastomotic), mycotic |
| Rupture risk | Related to size (Laplace's law) | Generally higher for equivalent size (thinner wall) |
- Fusiform: Circumferential, symmetrical dilatation — the more common form in degenerative TAA [2].
- Saccular: Only part of the circumference is involved, producing an asymmetric outpouching — classically associated with mycotic (infectious) aneurysms, penetrating atherosclerotic ulcers, or post-traumatic pseudoaneurysms.
- (Dissecting): Historically used but now better classified under acute aortic syndrome (see below) — blood enters a false lumen within the media [2].
Distinction from Acute Aortic Syndrome
TAA is a chronic structural disease — the aorta is too big. Acute aortic syndrome (aortic dissection, intramural haematoma, penetrating atherosclerotic ulcer) is a different entity where there is an acute event within the aortic wall. However, TAA is a risk factor for acute aortic syndrome, and acute aortic syndrome can lead to subsequent aneurysm formation. They are intimately related but distinct diagnoses [1][4].
Epidemiology
- TAA is less common than AAA but carries significant mortality if untreated.
- Incidence: approximately 6–10 per 100,000 person-years in Western populations. Autopsy studies suggest prevalence of ~1–3%.
- The incidence is rising — partly due to better detection (increased use of cross-sectional imaging, CT, echocardiography) and partly due to an ageing population.
- Age: Predominantly affects those >60 years; mean age at diagnosis is ~65–70 years.
- Sex: Overall male predominance (M:F ≈ 2–3:1), but the ratio varies by segment:
- Ascending aorta aneurysms: more equal sex distribution (bicuspid aortic valve and connective tissue disease affect both sexes).
- Descending thoracic aorta aneurysms: stronger male predominance (more atherosclerotic, similar risk profile to AAA).
- Ascending aorta (including aortic root): ~60% of all TAAs — the most common site.
- Descending thoracic aorta: ~35%.
- Aortic arch: ~10% (often in combination with ascending or descending involvement).
- Thoracoabdominal: ~10% (crossing the diaphragm).
Note: Percentages overlap because many aneurysms involve more than one segment.
- Exact local epidemiological data on TAA specifically is limited, but:
- Hypertension prevalence is high (~28% in adults), driving degenerative aortopathy.
- Bicuspid aortic valve prevalence is similar to global (~1–2% of population).
- Connective tissue diseases (Marfan syndrome, etc.) prevalence is similar to Western populations.
- Giant cell arteritis and Takayasu arteritis — both causes of aortitis leading to TAA — are seen in Hong Kong, with Takayasu arteritis being more common in Asian populations [5].
- Syphilitic aortitis is now rare but should still be considered in the differential.
Risk Factors
Understanding risk factors requires understanding why the thoracic aortic wall fails. The aorta's structural integrity depends on:
- Elastin fibres (provide compliance/recoil)
- Collagen fibres (provide tensile strength)
- Smooth muscle cells (maintain wall tone and secrete matrix)
- Extracellular matrix (ECM) homeostasis (balance of synthesis vs. degradation)
Anything that disrupts these components → wall weakening → aneurysm.
| Risk Factor | Mechanism |
|---|---|
| Age | Progressive elastin fragmentation and collagen cross-linking with age → "cystic medial degeneration" |
| Male sex | Androgens may promote MMP activity; oestrogen may be protective (pre-menopausal) |
| Genetic / Connective tissue diseases | Defective structural proteins (see below) |
| Bicuspid aortic valve (BAV) | Intrinsic aortopathy (not just haemodynamic — the ascending aorta wall is structurally abnormal in BAV even without valve dysfunction) — present in ~1–2% of the population but accounts for a disproportionate number of ascending TAAs |
| Family history | ~20% of TAA patients have a first-degree relative with aortic aneurysm/dissection — suggests heritable component even without identified syndromic cause |
| Risk Factor | Mechanism |
|---|---|
| Hypertension | ↑wall stress (Laplace's law: Wall tension = Pressure × Radius / Wall thickness) → accelerates medial degeneration; present in ~75% of TAA patients |
| Smoking | Promotes MMP activity, ↑oxidative stress, direct toxic effect on elastin and smooth muscle cells |
| Dyslipidaemia | Promotes atherosclerosis of vasa vasorum → ischaemic medial degeneration (more relevant for descending aorta) |
| Cocaine / Amphetamine use | Acute ↑BP → ↑wall stress; also direct vasotoxic effects |
DM is NOT a risk factor
Interestingly, diabetes mellitus is NOT a risk factor for aortic aneurysm (both AAA and TAA) — and may even be protective. The mechanism is unknown but may relate to increased collagen cross-linking from advanced glycation end-products (AGEs), which paradoxically strengthens the aortic wall [1].
These are critical because they affect young patients and have specific surgical thresholds:
| Condition | Gene / Defect | Key Features |
|---|---|---|
| Marfan syndrome | FBN1 (fibrillin-1) → defective microfibril scaffold for elastin + dysregulated TGF-β signalling | Tall, arachnodactyly, ectopia lentis, mitral valve prolapse, aortic root dilatation → dissection; AD inheritance |
| Ehlers-Danlos syndrome type IV (vascular type) | COL3A1 (type III collagen) → structurally defective collagen in vessel walls | Thin translucent skin, easy bruising, organ/arterial rupture; AD; highest vascular risk of all EDS types [2][4] |
| Loeys-Dietz syndrome | TGFBR1/TGFBR2 (TGF-β receptor mutations) → dysregulated TGF-β signalling | Hypertelorism, bifid uvula, arterial tortuosity, aggressive aneurysm formation at smaller diameters than Marfan; AD [4] |
| Turner syndrome (45,X) | Haploinsufficiency of X-linked genes → aortic wall defect | Short stature, webbed neck, BAV (30%), CoA, aortic dissection risk (even with relatively small aorta — use aortic size index) |
| Familial thoracic aortic aneurysm and dissection (FTAAD) | Multiple genes: ACTA2, MYH11, SMAD3, TGFB2, PRKG1, etc. | Non-syndromic — isolated aortic disease without the body habitus features; AD; accounts for ~20% of TAA |
| Cause | Mechanism |
|---|---|
| Aortitis | Inflammation weakens the aortic wall → aneurysm. Causes: Giant cell arteritis [5], Takayasu arteritis [5], IgG4-related disease, syphilitic aortitis (now rare — affects ascending aorta/arch, obliterative endarteritis of vasa vasorum → "tree-bark" calcification) |
| Mycotic (infectious) aneurysm | Infection of aortic wall (haematogenous seeding or contiguous spread) → focal destruction → typically saccular pseudoaneurysm. Common organisms: non-typhoid Salmonella (especially in Hong Kong/Asia), Staphylococcus aureus, Streptococcus, historically syphilis [1] |
| Post-stenotic dilatation | Turbulent flow distal to aortic stenosis (especially BAV) → ↑wall stress → ascending aorta dilatation |
| Chronic aortic dissection | False lumen progressively dilates → aneurysm of the dissected segment |
| Post-traumatic | Deceleration injury → intimal tear at aortic isthmus (where mobile arch meets fixed descending aorta) → pseudoaneurysm if patient survives [6] |
Anatomy and Function of the Thoracic Aorta
Understanding TAA requires solid knowledge of thoracic aortic anatomy, because the segment involved determines clinical features, complications, and surgical approach.
Segments of the Thoracic Aorta
- Contains the aortic valve and the coronary ostia (left and right coronary arteries arise from the left and right sinuses of Valsalva respectively).
- Normal diameter: ~3.0–3.5 cm.
- Composed largely of elastic tissue — allows the "Windkessel" function (stores energy during systole, releases during diastole to maintain diastolic perfusion, especially of the coronary arteries).
- Clinical relevance: Root dilatation (as in Marfan) → aortic regurgitation (annular dilatation prevents leaflet coaptation) and risk of coronary ostial involvement if dissection occurs.
- Extends from the sinotubular junction to the origin of the brachiocephalic (innominate) artery.
- Normal diameter: ~3.0–3.5 cm.
- Intrapericardial — this is crucial: rupture here → haemopericardium → cardiac tamponade (rapidly fatal).
- Clinical relevance: Aneurysm here may cause aortic regurgitation and is the most dangerous site for dissection (Stanford Type A).
- Gives rise to three great vessels (from proximal to distal):
- Brachiocephalic (innominate) artery → right subclavian + right common carotid
- Left common carotid artery
- Left subclavian artery
- Crosses over the left main bronchus and lies adjacent to the oesophagus, left recurrent laryngeal nerve (RLN), vagus nerve, and phrenic nerve.
- Clinical relevance: Arch aneurysm → compression of these structures → hoarseness (RLN), dysphagia, stridor.
- Begins distal to the left subclavian artery at the aortic isthmus (the "ligamentum arteriosum" landmark).
- Runs through the posterior mediastinum along the left side of the vertebral column.
- Gives off intercostal arteries (supply spinal cord via the artery of Adamkiewicz, typically arising at T9–T12), bronchial arteries, and oesophageal arteries.
- Clinical relevance:
- The isthmus is where traumatic aortic injury occurs (junction of mobile arch and fixed descending aorta) [6].
- Surgery or stenting of the descending aorta risks spinal cord ischaemia (paraplegia) if the artery of Adamkiewicz is compromised.
- Erosion into the oesophagus → aorto-oesophageal fistula (massive haematemesis).
- Erosion into the left lung → aorto-bronchial fistula (massive haemoptysis).
| Layer | Composition | Function | Relevance to TAA |
|---|---|---|---|
| Tunica intima | Endothelium + subendothelial connective tissue | Barrier, regulates vascular tone (NO) | Intimal tear → dissection entry point |
| Tunica media | Elastic lamellae (60–70 layers in thoracic aorta), smooth muscle cells, collagen, proteoglycans | Provides elasticity (Windkessel) and structural strength | Primary site of disease in TAA — "cystic medial degeneration" = loss of elastic fibres + smooth muscle cell dropout + mucoid degeneration |
| Tunica adventitia | Collagen, vasa vasorum, nervi vasorum | Provides outer structural support; vasa vasorum supply outer 2/3 of media | Ischaemia of vasa vasorum → medial degeneration; last barrier before rupture |
- These are "vessels of the vessel" — small arteries that supply the outer layers of the aortic wall.
- In the ascending aorta and arch, vasa vasorum are abundant (the wall is thick and cannot be nourished by luminal diffusion alone).
- Atherosclerosis of vasa vasorum → ischaemic medial degeneration → aneurysm (more relevant for descending aorta).
- Rupture of vasa vasorum into the media → intramural haematoma (part of acute aortic syndrome) [4].
- As the aorta dilates → radius increases → wall tension increases → further dilatation → vicious cycle.
- Simultaneously, as the wall stretches → wall thickness decreases → wall tension increases even more.
- This is why larger aneurysms grow faster and rupture more readily — the physics demands it.
- Hypertension worsens this by increasing the "Pressure" term.
Laplace's Law is the Key to Understanding TAA
Everything about TAA — why it grows, why it ruptures, why we control blood pressure, why surgical thresholds exist — comes back to Laplace's law. If you understand this one equation, you understand the disease.
Aetiology and Pathophysiology
The fundamental problem in TAA is a weakened aortic media [7]. The pathological hallmark is cystic medial degeneration (also called "cystic medial necrosis" or "medial degeneration"), characterised by:
- Loss of elastin and smooth muscle cells [7]
- Disruption of extracellular matrix [7]
- Deposition of adventitial collagen (attempted repair) [7]
- Wall thickening (paradoxically, from fibrosis, not from healthy tissue) [7]
- Inflammatory infiltrate (variable — more prominent in aortitis-related TAA) [7]
This weakens the wall → the aorta dilates under haemodynamic stress (Laplace's law) → progressive aneurysm formation.
Pathophysiology by Aetiology
- With ageing, there is progressive fragmentation of elastic lamellae and loss of smooth muscle cells in the media.
- Enhanced proteolytic activity: Matrix metalloproteinases (MMPs) — especially MMP-2 and MMP-9 — are upregulated [7]. These are zinc-dependent endopeptidases that degrade elastin and collagen in the ECM. When MMP activity exceeds that of their inhibitors (TIMPs — tissue inhibitors of metalloproteinases), net ECM degradation occurs.
- Atherosclerosis of vasa vasorum → medial ischaemia → accelerates degeneration.
- Hypertension and smoking are the key modifiable accelerators.
- Marfan syndrome: Fibrillin-1 deficiency → defective elastic fibre assembly + uncontrolled TGF-β activation (fibrillin-1 normally sequesters latent TGF-β) → excessive MMP activation, smooth muscle cell apoptosis, ECM degradation → aortic root dilatation (the root is especially elastin-rich).
- Loeys-Dietz syndrome: TGF-β receptor mutations → paradoxical increased TGF-β signalling (despite loss-of-function mutations, there is compensatory overactivation of alternative pathways) → aggressive medial degeneration at smaller diameters than Marfan.
- Ehlers-Danlos type IV: Defective type III collagen → the vessel wall simply cannot hold together → rupture risk is extreme, often without preceding significant dilatation.
- Bicuspid aortic valve (BAV): The aortopathy is intrinsic — BAV patients have fewer elastic fibres, more smooth muscle cell apoptosis, and increased MMP expression in their ascending aorta regardless of valve haemodynamics. This is thought to be due to shared embryological origin of the aortic valve and ascending aortic wall (neural crest cell defect). There may also be a haemodynamic component — the asymmetric jet from a bicuspid valve generates eccentric wall stress.
- Giant cell arteritis (GCA): Granulomatous inflammation of the aorta and its branches → destruction of the media → aneurysm formation [5]. GCA affects the thoracic aorta preferentially (compared to abdominal aorta). Patients with GCA have a 17-fold increased risk of thoracic aortic aneurysm. The aneurysm may present years after the initial GCA diagnosis, even after treatment.
- Takayasu arteritis: Granulomatous inflammation of the aorta and its major branches → stenosis, occlusion, or aneurysm formation [5]. More common in young Asian women. The thoracic aorta (especially the arch) is characteristically involved.
- IgG4-related aortitis: Dense lymphoplasmacytic infiltrate with IgG4-positive plasma cells → inflammatory aneurysm.
- Syphilitic aortitis: Treponema pallidum causes obliterative endarteritis of the vasa vasorum → medial ischaemia and necrosis → aneurysm (classically ascending aorta and arch, with "tree-bark" calcification on imaging). This is tertiary syphilis and now very rare with antibiotic treatment.
- "Mycotic" is a misnomer — it doesn't mean fungal. The term was coined by Osler (1885) because the infected aneurysm resembled a fungal growth.
- Mechanism: Bacteria seed the aortic wall (haematogenous spread, contiguous infection, or direct inoculation during procedures) → focal aortitis → wall destruction → rapidly expanding saccular pseudoaneurysm.
- Key organisms (especially relevant in Hong Kong):
- Non-typhoid Salmonella: The classic organism in Asian populations — has tropism for diseased/atherosclerotic aortic wall. Think of this in any elderly patient with fever + back pain + known aortic disease [1].
- Staphylococcus aureus: Acute, aggressive.
- Streptococcus spp.
- Mycobacterium tuberculosis: Rare but important in endemic areas (contiguous spread from vertebral TB — Pott's disease).
- High-speed deceleration injury → intimal tear at the aortic isthmus (junction of mobile arch and fixed descending aorta, at the ligamentum arteriosum) [6].
- 80–90% die at the scene [6]. Those who survive do so because the adventitia and mediastinal haematoma contain the rupture → pseudoaneurysm.
- If untreated, 30% die within 6 hours, 40–50% within 24 hours, and 90% within 4 months [6].
- After an acute aortic dissection, the false lumen may remain patent and progressively dilate under systemic pressure → post-dissection aneurysm. This is a common long-term complication and the reason for lifelong surveillance imaging after dissection [4].
Classification
The Crawford classification (originally for thoracoabdominal aneurysms) and general anatomical classification:
| Type | Segment | Common Aetiology | Key Considerations |
|---|---|---|---|
| Aortic root | Sinuses of Valsalva | Marfan, BAV, annuloaortic ectasia | Aortic regurgitation, Bentall procedure |
| Ascending aorta | Sinotubular junction to innominate artery | Marfan, BAV, degenerative, GCA | Intrapericardial → tamponade risk; Stanford Type A dissection territory |
| Aortic arch | Between innominate and left subclavian | Degenerative, Takayasu, atherosclerotic | Complex surgery — involves great vessels, cerebral perfusion |
| Descending thoracic | Distal to left subclavian to diaphragm | Degenerative, atherosclerotic, post-traumatic, chronic dissection | Spinal cord ischaemia risk; TEVAR preferred |
| Thoracoabdominal | Crosses diaphragm, involves both thoracic and abdominal aorta | Chronic dissection, degenerative | Crawford classification (Types I–IV); most complex surgery |
| Type | Extent |
|---|---|
| I | Distal to left subclavian → above renal arteries |
| II | Distal to left subclavian → below renal arteries (most extensive) |
| III | From mid-descending aorta → below renal arteries |
| IV | Below diaphragm → below renal arteries (essentially a large AAA extending proximally) |
- Fusiform (more common) vs. Saccular [2]
- True (all 3 layers) vs. False/Pseudo (connective tissue only) [2]
Most TAAs are Asymptomatic
The majority of thoracic aortic aneurysms are asymptomatic and discovered incidentally on imaging (CXR, CT, echocardiography) performed for other indications. Symptoms, when they occur, usually indicate a large or rapidly expanding aneurysm — and should raise concern for impending rupture or dissection [2].
Symptoms
A. Symptoms Related to the Aneurysm Itself (Compression / Mass Effect)
The thoracic aorta sits in a crowded neighbourhood. As the aneurysm enlarges, it compresses adjacent structures. The specific symptoms depend on which segment is involved:
| Symptom | Structure Compressed / Mechanism | Segment Most Commonly Involved | Pathophysiological Explanation |
|---|---|---|---|
| Chest pain / back pain | Stretching of the aortic wall (medial stretching activates nociceptive nerve endings in the adventitia/periaortic tissue) | Any segment | Dull, deep, often poorly localised. Acute onset or worsening pain = red flag for impending rupture or dissection |
| Hoarseness of voice | Left recurrent laryngeal nerve (RLN) compression — the left RLN loops under the aortic arch and is vulnerable to compression by arch/proximal descending aneurysms | Aortic arch / proximal descending | This is called Ortner syndrome (cardiovocal syndrome). The RLN innervates all intrinsic laryngeal muscles except cricothyroid → compression → left vocal cord paralysis → hoarseness |
| Dysphagia | Oesophageal compression (the oesophagus lies directly posterior to the aortic arch and descending aorta) | Arch / descending | Called dysphagia aortica. Progressive difficulty swallowing, initially to solids |
| Stridor / cough / dyspnoea | Tracheal or left main bronchus compression | Arch / ascending | The trachea and left main bronchus lie anterior and inferior to the arch respectively. Compression → airway narrowing → stridor (if extrathoracic/upper), wheezing, cough, or dyspnoea |
| Superior vena cava (SVC) syndrome | SVC compression by ascending aortic or arch aneurysm | Ascending / arch | Facial plethora, distended neck veins, upper limb oedema — rare with TAA, more common with malignancy |
| Chest wall pain / erosion | Direct erosion into sternum, ribs, or vertebral bodies by a large aneurysm | Ascending (anterior erosion) / Descending (vertebral erosion) | Chronic pulsatile erosion → bone destruction → visible pulsatile mass on chest wall (very rare, very dramatic) |
B. Symptoms Related to Aortic Valve Involvement
| Symptom | Mechanism |
|---|---|
| Dyspnoea on exertion, orthopnoea, PND | Aortic root / ascending aorta dilatation → aortic regurgitation (annular dilatation prevents leaflet coaptation) → LV volume overload → LV failure → pulmonary oedema [8] |
| Palpitations / awareness of heartbeat | Increased stroke volume from AR → hyperdynamic circulation |
| Angina | ↓Diastolic BP from AR → ↓coronary perfusion pressure + ↑LV wall stress from dilatation → supply-demand mismatch |
C. Symptoms Related to Thromboembolism
- Mural thrombus forms within the aneurysm sac (sluggish flow, turbulence) → embolisation to:
- Cerebral circulation (from ascending/arch aneurysm) → stroke / TIA
- Upper limbs (from arch aneurysm) → acute limb ischaemia
- Visceral / lower limbs (from descending aorta) → mesenteric ischaemia, renal infarction, blue toe syndrome
D. Symptoms of Rupture (Emergency)
| Symptom | Explanation |
|---|---|
| Sudden, severe chest or back pain | Acute transmural tear → blood escapes into mediastinum / pleural space / pericardium |
| Haemodynamic collapse / shock | Massive haemorrhage |
| Massive haematemesis | Aorto-oesophageal fistula — aneurysm erodes into oesophagus. **Chiari tr |
Differential Diagnosis of Thoracic Aortic Aneurysm
When you encounter a patient with suspected TAA — or more commonly, when you encounter the presenting symptoms of TAA (chest/back pain, widened mediastinum on CXR, aortic regurgitation, hoarseness, dysphagia) — you need a systematic differential. Remember, most TAAs are asymptomatic and found incidentally, so the DDx really depends on the clinical scenario that brought the patient to attention.
Let's approach this logically by the mode of presentation.
This is the most common scenario: a CXR done for another reason shows a widened mediastinum or a mediastinal mass. You need to differentiate TAA from other causes of mediastinal widening.
| Category | Differential | How to Differentiate from TAA |
|---|---|---|
| Vascular | Aortic dissection (acute aortic syndrome) [1][2] | Acute onset, tearing pain radiating to back, asymmetric BP/pulses. CT aortogram shows intimal flap + true/false lumen rather than simple aneurysmal dilatation. NB: dissection and aneurysm can coexist |
| Tortuous / unfolded aorta (age-related aortic elongation) | Very common in elderly — the aorta elongates and unfolds, creating apparent widening on CXR. CT shows no true dilatation > 50% | |
| Aortic pseudoaneurysm (post-traumatic) [6] | History of trauma / deceleration injury. Located at aortic isthmus. CT shows contained rupture with mediastinal haematoma | |
| Neoplastic | Mediastinal lymphadenopathy (lymphoma, metastatic carcinoma, sarcoidosis) | Lobulated mass, often multiple nodes. No continuity with aortic lumen on contrast CT. Biopsy may be needed |
| Thymoma / thymic carcinoma | Anterior mediastinum. Not in continuity with aorta | |
| Retrosternal goitre | Continuous with thyroid on CT. Displaces trachea. Iodine uptake on nuclear scan | |
| Neurogenic tumour (schwannoma, neurofibroma) | Posterior mediastinum, paraspinal. Enhances differently from aorta on CT | |
| Other | Mediastinal haematoma (without aneurysm — e.g., vertebral fracture, mediastinitis) | History of trauma, recent procedure, or infection. CT shows haematoma without aortic dilatation |
| Pericardial effusion (can mimic widened cardiac silhouette/mediastinum) | Echocardiography diagnostic. Globular heart shadow on CXR |
This is where it gets life-threatening. The key question: is this an acute aortic emergency or something else?
| Category | Differential | Key Distinguishing Features |
|---|---|---|
| Aortic emergencies | Acute aortic dissection [1][2] | Sudden onset, tearing pain, radiating to back. Asymmetric BP & pulse between arms [1]. May cause MI, stroke, limb ischaemia, tamponade [1]. CT aortogram: intimal flap |
| Ruptured TAA | Sudden severe chest/back pain + haemodynamic collapse. May present with haemothorax (left-sided) or tamponade (ascending). CT: contrast extravasation | |
| Intramural haematoma (IMH) [1] | Similar presentation to dissection. CT: crescentic high-attenuation thickening of aortic wall without intimal flap or false lumen flow | |
| Penetrating atherosclerotic ulcer (PAU) [1] | Elderly, atherosclerotic. CT: focal contrast-filled outpouching into aortic wall with surrounding haematoma | |
| Cardiac | Acute coronary syndrome (ACS) [3][4] | Dull, constricting chest pain, not tearing [4]. Troponin elevated. ECG changes. No mediastinal widening. Important: dissection from a TAA can occlude a coronary ostium → secondary MI, so always think of aortic pathology if MI + unusual features |
| Myopericarditis [3] | Pleuritic, positional (better sitting forward). Diffuse ST elevation. Pericardial rub | |
| Pulmonary | Pulmonary embolism (PE) [3] | Pleuritic pain, acute SOB, tachycardia. Risk factors for VTE. CT pulmonary angiogram diagnostic |
| Tension / massive pneumothorax [3] | Sudden pleuritic pain, absent breath sounds, tracheal deviation. CXR diagnostic | |
| Pneumonia [3] | Fever, productive cough, consolidation on CXR | |
| GI | GERD / oesophageal spasm [3] | Retrosternal burning, related to meals, relieved by antacids. Normal aorta on imaging |
| Boerhaave syndrome (oesophageal perforation) | Severe retching/vomiting preceding pain. Pneumomediastinum on CXR. Contrast swallow diagnostic | |
| Musculoskeletal | Costochondritis, rib fracture [3] | Reproducible with palpation. No mediastinal abnormality |
| Spinal | Vertebral collapse / disc disease | Back pain, neurological signs, bony tenderness. MRI spine diagnostic |
The 'Big Five' of Acute Chest Pain
Never forget the five life-threatening causes of acute chest pain — you must rule these in or out urgently in every patient [3][4]:
- Acute coronary syndrome
- Aortic dissection (± ruptured TAA)
- Pulmonary embolism
- Tension pneumothorax
- Cardiac tamponade (may be caused by ruptured ascending TAA or dissection)
| Symptom | DDx Besides TAA | How to Differentiate |
|---|---|---|
| Hoarseness (left RLN palsy) | Lung carcinoma (especially left apical / Pancoast), mediastinal lymphadenopathy, thyroid carcinoma, post-thyroidectomy, idiopathic vocal cord palsy | CT thorax shows whether the RLN is compressed by an aneurysm vs. tumour. Laryngoscopy confirms vocal cord palsy |
| Dysphagia | Oesophageal carcinoma, stricture, achalasia, extrinsic compression by lymph nodes, dysphagia lusoria (aberrant right subclavian artery), dysphagia aortica [5][9] | OGD for intraluminal causes. CT/barium swallow for extrinsic compression. Dysphagia aortica is specifically due to TAA compressing the oesophagus [5][9] |
| Stridor / dyspnoea | Tracheal tumour, goitre, tracheomalacia, foreign body | CT and bronchoscopy differentiate |
| SVC syndrome | Lung carcinoma, lymphoma, mediastinal fibrosis, thrombosis (central line-related) | CT with contrast defines the cause |
When you find AR on echo, you must determine whether the problem is the valve leaflets or aortic root/ascending aorta dilatation — because the treatment differs fundamentally.
| Cause of AR | Key Features |
|---|---|
| Aortic root / ascending aorta dilatation (TAA) | Dilated root on echo/CT. Leaflets structurally normal but fail to coapt due to annular dilatation. Associated with Marfan syndrome, syphilitic aortitis, degenerative aneurysm [8] |
| Rheumatic heart disease | History of rheumatic fever, leaflet thickening/calcification, often with MS |
| Infective endocarditis | Fever, positive blood cultures, vegetations on echo, embolic phenomena |
| Congenital bicuspid aortic valve | Two leaflets on echo. May have both stenosis and regurgitation. Associated ascending aortopathy |
| Ruptured sinus of Valsalva aneurysm | Acute AR, continuous murmur, into RV or LV [8] |
| Spondyloarthropathy | Aortic root fibrosis → AR. Look for axSpA features (back pain, sacroiliitis, HLA-B27) [10] |
Once you've confirmed the TAA on imaging, the next question is: why does this patient have a TAA? This is important because the underlying aetiology determines surgical thresholds, surveillance intervals, and screening of family members.
Here is a consolidated summary you can use as a clinical thinking tool:
| Presentation Scenario | Primary DDx to Consider | Most Dangerous "Must Not Miss" |
|---|---|---|
| Incidental widened mediastinum on CXR | TAA, aortic unfolding, mediastinal mass (lymphoma, thymoma, goitre) | TAA (risk of rupture/dissection) |
| Acute severe chest/back pain | Aortic dissection, ruptured TAA, ACS, PE, tension PTX, tamponade, Boerhaave | Aortic dissection / ruptured TAA |
| Hoarseness + mediastinal abnormality | TAA (Ortner syndrome), lung CA, mediastinal LN, thyroid CA | Lung carcinoma |
| Progressive dysphagia | Oesophageal CA, stricture, achalasia, dysphagia aortica from TAA [5][9], dysphagia lusoria | Oesophageal carcinoma |
| New AR on echo | Aortic root aneurysm (TAA), BAV, RHD, IE, syphilitic aortitis | IE (acute), TAA with dissection risk |
| Young patient with aortic dilatation | Marfan, Loeys-Dietz, BAV aortopathy, familial TAAD, Turner, Takayasu | Genetic cause (needs family screening + lower surgical threshold) |
This is worth emphasizing because students often confuse these:
| Feature | Thoracic Aortic Aneurysm | Aortic Dissection |
|---|---|---|
| Nature | Chronic structural disease (dilated aorta) | Acute event (tear in aortic wall) |
| Pain | Usually painless; if painful, chronic dull ache | Sudden onset, tearing, maximal at onset, radiates to back [1][4] |
| Onset | Gradual (months-years) | Acute (seconds-minutes) |
| Pulses | Usually symmetric (unless thromboembolism) | Asymmetric BP & pulse [1] |
| CT finding | Dilated aorta, no intimal flap | Intimal flap, true + false lumen |
| Relationship | TAA is a risk factor for dissection | Dissection can cause subsequent aneurysm (chronic dissection → false lumen expansion) |
| Emergency? | Not usually (unless ruptured) | Always an emergency |
TAA and Dissection Can Coexist
A patient with a known TAA can acutely dissect — indeed, pre-existing aneurysm is a risk factor for dissection [2]. If a patient with known TAA develops sudden severe pain, treat as dissection until proven otherwise. Additionally, Type B dissection managed medically requires lifelong surveillance because the false lumen can progressively dilate → post-dissection aneurysm → requiring late intervention [2].
High-Yield Summary for DDx:
- The DDx of TAA depends on how it presents: widened mediastinum, acute chest/back pain, compressive symptoms, AR, or incidental imaging finding.
- The most critical differentiation is TAA vs. acute aortic dissection — different management urgency.
- For acute chest/back pain: always consider the "Big Five" life-threatening causes (ACS, dissection, PE, tension PTX, tamponade).
- For widened mediastinum: TAA vs. mediastinal mass vs. aortic unfolding.
- Once TAA is confirmed, determine the aetiology (degenerative vs. genetic vs. inflammatory vs. infectious vs. post-traumatic) — this changes surgical thresholds and family screening.
- Dysphagia aortica and Ortner syndrome (hoarseness from RLN compression) are characteristic compressive presentations of TAA [5][7][9].
High Yield Summary
- Most TAAs are asymptomatic — DDx arises when they present with pain, compression, AR, or as an incidental mediastinal finding.
- Acute chest/back pain DDx: Aortic dissection, ACS, PE, tension PTX, tamponade — the "Big Five" [3][4].
- Widened mediastinum DDx: TAA, dissection, mediastinal lymphadenopathy, thymoma, retrosternal goitre, aortic unfolding.
- Compressive symptom DDx: Hoarseness → RLN palsy (TAA vs. lung CA vs. thyroid CA). Dysphagia → TAA (dysphagia aortica) vs. oesophageal CA vs. achalasia [5][9].
- AR DDx: Root dilatation from TAA vs. leaflet disease (RHD, IE, BAV) [8].
- Young patient with TAA: Always think genetic — Marfan, Loeys-Dietz, EDS IV, BAV aortopathy, familial TAAD, Turner syndrome → lower surgical thresholds + family screening.
- Aortitis causing TAA: GCA (elderly, high ESR), Takayasu (young Asian female), IgG4-related, syphilitic [5][7].
- Mycotic aneurysm: Fever + saccular aneurysm → non-typhoid Salmonella (Asia), S. aureus, Streptococcus [1].
- TAA is a risk factor for dissection; chronic dissection can cause secondary TAA — they are related but distinct entities.
Active Recall - Differential Diagnosis of TAA
References
[1] Senior notes: Maksim Surgery Notes.pdf (Ch 7.1, Aneurysm / AAA) [2] Senior notes: Ryan Ho Cardiology.pdf (Section 4.5.2, Aortic Aneurysms) [3] Senior notes: Ryan Ho Cardiology.pdf (Section 2.1, Chest Pain) [4] Senior notes: Ryan Ho Fundamentals.pdf (Section 3.1.1, Chest Pain) [5] Senior notes: Ryan Ho Rheumatology.pdf (Section 3.6.1, GCA and PMR; Section 3.6.2, Takayasu Arteritis) [6] Senior notes: Ryan Ho Radiology.pdf (Acute Traumatic Aortic Injury) [7] Lecture slides: GC 199. Pulsating abdominal mass aortic aneurysm.pdf [8] Senior notes: Ryan Ho Cardiology.pdf (Section on Aortic Regurgitation) [9] Senior notes: Ryan Ho GI.pdf (Section on Dysphagia, CVS causes) [10] Senior notes: Ryan Ho Rheumatology.pdf (Section on Spondyloarthropathy, Cardiovascular manifestations)
Diagnostic Criteria, Diagnostic Algorithm, and Investigation Modalities for Thoracic Aortic Aneurysm
Diagnostic Criteria — "How Do We Define and Confirm TAA?"
Unlike conditions such as rheumatic fever or SLE, there are no formal "classification criteria" with point scores for TAA. The diagnosis is fundamentally an imaging diagnosis — you measure the aorta and determine whether it meets the size threshold. However, the clinical reasoning process involves several steps.
Recall the definition from first principles:
- Aneurysm = permanent, localized dilatation of an artery by ≥50% of its normal diameter [1][2]
- The normal thoracic aortic diameter varies by segment, age, sex, and body surface area (BSA):
| Segment | Approximate Normal Diameter | TAA Threshold (≥50% dilatation) |
|---|---|---|
| Aortic root (sinuses of Valsalva) | 3.0–3.5 cm | ≥4.5 cm (varies by BSA/sex) |
| Ascending aorta | 3.0–3.5 cm | ≥4.5 cm |
| Aortic arch | 2.5–3.0 cm | ≥3.5–4.0 cm |
| Descending thoracic aorta | 2.0–2.5 cm | ≥3.5 cm |
Why does BSA matter? Because a 190 cm tall man naturally has a larger aorta than a 150 cm tall woman. Using an absolute cut-off alone could over-diagnose petite patients and under-diagnose tall patients. The aortic size index (ASI) = aortic diameter / BSA (cm/m²) is used especially in connective tissue diseases and Turner syndrome. An ASI > 2.75 cm/m² is considered aneurysmal for the ascending aorta.
Aortic Ectasia vs. Aneurysm
If the dilatation is < 50% of normal (e.g., a 3.8 cm ascending aorta in a large man), this is termed aortic ectasia — not yet an aneurysm, but it needs surveillance because it may progress [2].
The diagnosis requires cross-sectional imaging demonstrating the dilated aortic segment:
- CT aortogram (CTA) — the workhorse investigation (see below)
- Echocardiography (TTE/TEE) — especially for aortic root and ascending aorta
- MR angiography (MRA) — radiation-free alternative, excellent for surveillance
Once TAA is confirmed, you must investigate the underlying cause — this directly impacts management thresholds and family screening:
- Syndromic features → genetic testing (Marfan, Loeys-Dietz, EDS IV)
- Bicuspid aortic valve → echocardiography
- Inflammatory markers → aortitis (GCA, Takayasu)
- Infection → blood cultures, PET-CT
- Family history → screening first-degree relatives
- Aortic regurgitation → echocardiography
- Branch vessel involvement → CTA
- Signs of impending rupture (rapid growth, pain) → urgent intervention
The approach differs depending on whether the patient presents acutely (with pain/haemodynamic instability — suspect rupture or dissection) or chronically (incidental finding or surveillance).
Investigation Modalities — Detailed
Let me walk you through each investigation modality systematically — what it shows, why we do it, and how to interpret the findings.
Role: Often the first clue — TAA is frequently discovered incidentally on CXR done for other reasons.
Why it works: The thoracic aorta is a mediastinal structure. When it dilates, it changes the mediastinal contour.
| CXR Finding | What It Means | Pathophysiological Explanation |
|---|---|---|
| Widened mediastinum | Dilatation of the aorta pushes mediastinal borders outward | The mediastinum contains the aorta; enlargement widens the mediastinal silhouette [3][11] |
| Abnormal aortic knuckle (prominent or enlarged) | Dilatation of the aortic arch | The "aortic knuckle" is the normal shadow of the aortic arch on PA CXR; aneurysmal dilatation makes it more prominent or irregular |
| Loss of aortic knuckle | Suggests acute pathology (dissection, ATAI) rather than chronic TAA | Loss of the normal contour implies disruption of the wall, not just dilatation [6] |
| Tracheal deviation (to the right) | Mass effect from a left-sided arch/descending aneurysm | The trachea is pushed away from the expanding aneurysm |
| Calcification of aortic wall | Outlines the aneurysm wall | Chronic atherosclerotic or syphilitic aneurysms develop wall calcification — helps estimate the true outer diameter [1] |
| Left pleural effusion | May indicate contained rupture or inflammatory process | Blood leaks into left pleural space from descending TAA (the descending aorta abuts the left pleura) |
| Displaced oesophagus (deviation of nasogastric tube) | Oesophagus pushed by aneurysm | The oesophagus lies posterior to the aorta; large aneurysms displace it [6] |
CXR Limitations
CXR has low sensitivity for TAA — a normal CXR does NOT exclude TAA. Many aneurysms, especially of the ascending aorta, may not cause visible mediastinal widening. CXR also cannot measure the aorta accurately and cannot distinguish TAA from dissection. Always proceed to cross-sectional imaging if clinical suspicion exists.
Role: The primary diagnostic and pre-operative planning investigation for TAA [2][6][11].
"CT aortogram" = CT with IV contrast, timed to the arterial phase, from the aortic arch to the bifurcation (or from thoracic inlet to pelvis for full assessment). It is essentially a CT angiography focused on the aorta [11].
Why it's first-line:
- Widely available, fast ( < 10 minutes), non-operator-dependent
- Exquisite anatomical detail — can measure diameter to the nearest millimetre
- Shows the entire aorta in one study (unlike echo which only sees parts)
- Can identify complications (rupture, dissection, branch involvement)
- Essential for pre-operative planning — determines whether open repair or endovascular repair (TEVAR) is feasible [1]
| CT Aortogram Finding | Interpretation | Clinical Significance |
|---|---|---|
| Dilated aortic segment ≥50% of normal | Confirms TAA | Diagnostic |
| Maximum diameter measurement | Determines surgical threshold and surveillance interval | The single most important measurement — dictates management |
| Mural thrombus | Layered thrombus within the aneurysm sac | Common in large TAA; reduces effective lumen but does NOT reduce rupture risk (wall stress is determined by outer diameter, not lumen size — Laplace's law applies to the outer wall) |
| Wall calcification | Chronic degenerative or atherosclerotic aneurysm | Helps distinguish from acute pathology; also helps identify the outer wall boundary |
| Contrast extravasation | Active rupture | Surgical emergency — blood is leaking outside the aorta |
| Periaortic haematoma / mediastinal haematoma | Contained rupture or recent leak | Urgent intervention needed [6] |
| Intimal flap with true and false lumen | Aortic dissection (may coexist with TAA) | True lumen is compressed by false lumen; true lumen is more hyperdense (new contrast-filled blood), false lumen is more hypodense (older stagnant blood) [3] |
| Crescentic high-attenuation wall thickening (non-contrast) | Intramural haematoma | Acute aortic syndrome variant — manage as dissection [3] |
| Focal ulcer-like projection with subadventitial haematoma | Penetrating atherosclerotic ulcer | Another acute aortic syndrome variant [3] |
| Relationship to branch vessels | Involvement of coronary ostia, great vessels, intercostal arteries, visceral arteries | Critical for surgical planning — determines need for bypass/reimplantation |
| Neck anatomy (for descending TAA) | Length, angulation, diameter of proximal and distal landing zones | Determines suitability for TEVAR (similar concept to EVAR for AAA) |
Important: Conventional angiography (DSA) should NOT be used to assess aneurysm size because aneurysms are often lined with circumferential thrombus, giving a falsely narrowed appearance of the lumen that does not reflect the true outer diameter [2]. CT measures the entire wall, including thrombus.
How to measure: Always measure the maximum external diameter perpendicular to the long axis of the aorta (i.e., the true short-axis diameter). Oblique cuts on axial images can overestimate diameter — use multiplanar reformats (MPR) or centreline reconstructions.
Role: Best for the aortic root and proximal ascending aorta; also assesses aortic valve function.
| Modality | What It Sees | Strengths | Limitations |
|---|---|---|---|
| Transthoracic Echo (TTE) | Aortic root, sinuses of Valsalva, proximal ascending aorta (~first 3–4 cm), aortic valve | Non-invasive, bedside, no radiation, repeatable. Excellent for root measurements and AR assessment | Cannot visualize the distal ascending aorta, arch, or descending thoracic aorta [12]. Operator-dependent. Limited by body habitus |
| Transoesophageal Echo (TEE) | Aortic root, ascending aorta, arch (partial — "blind spot" at distal ascending/proximal arch due to tracheal air), descending thoracic aorta | More sensitive than TTE for aortic pathology [3]. Excellent for dissection (intimal flap), pericardial effusion, AR | Semi-invasive (requires sedation). Cannot see entire arch. Preferred over TTE for acute aortic syndrome [3][12] |
Key Echo Findings in TAA:
| Finding | Significance |
|---|---|
| Dilated aortic root / ascending aorta | Confirms aneurysm; measure at standard levels: sinuses of Valsalva, sinotubular junction, mid-ascending aorta |
| Aortic regurgitation (AR) | Indicates annular dilatation from root aneurysm → central AR jet (vs. eccentric in leaflet disease). Quantify severity (mild/moderate/severe) — determines urgency of surgery |
| LV dilatation, ↓LVEF | Chronic AR → LV volume overload → eventually decompensation. Triggers earlier surgical intervention |
| Pericardial effusion | May indicate rupture of ascending TAA into pericardium → tamponade [3] |
| Bicuspid aortic valve | Identifies the underlying aetiology; BAV patients have intrinsic ascending aortopathy |
| Intimal flap | Aortic dissection — TEE can visualise the flap oscillating in the lumen [3] |
| RWMA (regional wall motion abnormalities) | May indicate coronary ostial involvement (dissection extending to coronaries → secondary MI) [3] |
Role: Gold-standard for surveillance imaging (no radiation, no iodinated contrast needed for some sequences).
| Feature | Detail |
|---|---|
| Strengths | No radiation (ideal for young patients requiring lifelong surveillance, e.g., Marfan). No iodinated contrast needed (gadolinium-enhanced or non-contrast techniques available). Excellent soft tissue contrast. Can assess flow dynamics. Highly reproducible for serial measurements |
| Limitations | Slower than CT (20–45 min vs. < 10 min). Contraindicated with certain metallic implants (pacemakers, some mechanical valves). Not suitable for haemodynamically unstable patients (too slow, monitoring equipment incompatible). Less spatial resolution for small branch vessels than CT [12] |
| Key findings | Same as CTA — measures diameter, identifies thrombus, assesses branch involvement. Can also assess aortic wall inflammation with late gadolinium enhancement (useful for aortitis) |
MRI is unsuitable for pacing wiring and life support equipment — this is why CTA is preferred in acute situations [12].
Surveillance Protocol
For stable, asymptomatic TAA below surgical threshold, current guidelines (2022 ACC/AHA) recommend:
- First follow-up: Repeat imaging at 6 months after initial diagnosis to assess growth rate.
- If stable: Annual imaging (CTA or MRA) thereafter.
- If growing > 0.5 cm/year: More frequent imaging (every 3–6 months) and consider intervention.
- Preferred modality for long-term surveillance: MRA (avoids cumulative radiation and contrast nephrotoxicity).
- Serial imaging at 3, 6, 12 months is recommended after aortic dissection repair to detect recurrence, aneurysm formation, or endoleak [2].
Role: Historically the gold standard for vascular imaging, now largely replaced by CTA/MRA for diagnosis [6][1].
| Feature | Detail |
|---|---|
| Technique | Catheter inserted (usually via femoral artery) → radiopaque contrast injected → images digitally subtracted to show vessels only [1] |
| Strengths | Highest spatial resolution. Can be combined with intervention (e.g., TEVAR deployment) — i.e., diagnostic and therapeutic in one procedure |
| Limitations | Invasive (arterial access). Risks: arterial injury (dissection, pseudoaneurysm), thromboembolism, contrast nephropathy, radiation. Should NOT be used to assess aneurysm size (intramural thrombus → false lumen narrowing → underestimates true diameter) [2]. Almost never done for diagnosis alone — reserved for endovascular intervention [6] |
Blood tests do not diagnose TAA per se, but they are essential for aetiological workup, pre-operative assessment, and ruling out differentials/complications.
| Blood Test | Purpose | Key Findings / Interpretation |
|---|---|---|
| CBC | Baseline; identify anaemia (chronic blood loss if fistula), leucocytosis (infection/inflammation) | Normochromic normocytic anaemia (NcNc) in GCA [5]; leucocytosis in mycotic aneurysm |
| ESR / CRP | Screen for inflammatory aortitis | Very high ESR (often > 100 mm/h) + ↑CRP in GCA [5]; ↑ESR/CRP in Takayasu arteritis [5]. Normal inflammatory markers make aortitis unlikely but do not exclude it |
| Troponin | Rule out MI (especially if chest pain — dissection from TAA can involve coronary ostia) [3] | Elevated in myocardial ischaemia/infarction |
| Lactate | Elevated in ischaemic gut / shock [3] | Suggests visceral malperfusion (if dissection involves mesenteric arteries) or haemodynamic shock from rupture |
| Renal function (Cr/eGFR) | Baseline for contrast use; assess for renal involvement | Elevated if renal artery involved by dissection or pre-existing CKD (affects contrast decisions) |
| Liver function | Pre-operative baseline | Deranged if hepatic congestion from tamponade or shock |
| Coagulation (PT/INR, aPTT) | Pre-operative baseline; assess for DIC in massive haemorrhage | Deranged in DIC (ruptured TAA with massive bleeding) |
| Blood group + crossmatch | Pre-operative | Always crossmatch if surgical intervention anticipated |
| Syphilis serology (RPR/VDRL, TPHA/FTA-ABS) | Screen for syphilitic aortitis if ascending aorta/arch aneurysm in relevant demographic | Positive in tertiary syphilis |
| Blood cultures | If mycotic aneurysm suspected (fever + saccular aneurysm) | Positive for causative organism (Salmonella, S. aureus, Streptococcus) |
| Genetic testing | If syndromic cause suspected | FBN1 (Marfan), TGFBR1/2 (Loeys-Dietz), COL3A1 (EDS IV), ACTA2/MYH11 (familial TAAD) |
Role: Not diagnostic for TAA, but essential in the acute setting to rule out differentials and identify complications.
| ECG Finding | Significance |
|---|---|
| Normal | Does not exclude TAA or dissection |
| ST elevation / depression | May indicate ACS (differential) OR secondary MI from dissection involving coronary ostia. If inferior ST elevation + aortic pathology → think right coronary artery involvement from Type A dissection |
| Low voltage | May suggest pericardial effusion (from ascending TAA rupture into pericardium) |
| LVH | Chronic hypertension (risk factor for TAA) or chronic AR causing LV hypertrophy |
| Arrhythmia | Non-specific but may occur with haemodynamic compromise |
Role: Increasingly used to assess aortic wall inflammation — especially in suspected aortitis or mycotic aneurysm.
| Feature | Detail |
|---|---|
| Principle | 18F-fluorodeoxyglucose (FDG) is taken up by metabolically active cells, including activated inflammatory cells (macrophages, lymphocytes). Increased FDG uptake in the aortic wall indicates active inflammation |
| Indications | Suspected GCA with large vessel involvement; Takayasu arteritis (assess disease activity); suspected mycotic aneurysm; fever of unknown origin with aortic pathology |
| Limitations | Cannot distinguish between infection and sterile inflammation. Normal atherosclerotic plaque can show mild FDG uptake. Not widely available for this indication |
This term refers to contrast injection into the aorta under fluoroscopy — essentially DSA of the aorta. As discussed, this is rarely done for diagnosis alone but may be performed intraoperatively to guide endovascular repair [6].
The major operative mortality for aortic surgery is myocardial infarction [7]. Therefore, pre-operative cardiac assessment is critical.
| Assessment | Why |
|---|---|
| Blood tests, ECG, CXR [7] | Baseline investigations |
| Cardiac assessment / intervention [7] | Evaluate coronary artery disease (stress test, coronary angiography ± PCI before elective aortic repair if significant CAD found) |
| Pulmonary function tests | Thoracotomy/sternotomy → significant impact on respiratory function. Identify patients who may not tolerate open repair |
| Renal function | Baseline; plan for renal protection during cross-clamping |
| Monitors, blood [7] | Ensure adequate crossmatched blood available; plan for invasive monitoring (arterial line, central line, PA catheter) |
Suprarenal / Thoracoabdominal Aneurysm — Special Considerations
Suprarenal and thoracoabdominal aneurysms involve complex surgical challenges not present in infrarenal AAA repair [7]:
- High aortic clamp → severe proximal hypertension (the heart pumps against a clamped aorta)
- Critical ischaemic time for visceral/renal organs and spinal cord
- Need to bypass and reimplant visceral arteries (coeliac, SMA, renal)
- Spinal ischaemia risk → paraplegia (from loss of the artery of Adamkiewicz) These considerations make TEVAR or hybrid approaches increasingly preferred where anatomically feasible.
| Modality | Sensitivity for TAA | Measures Size Accurately? | Shows Complications? | Radiation | Contrast | Best For |
|---|---|---|---|---|---|---|
| CXR | Low (screening only) | No | Widened mediastinum, effusion | Minimal | No | First clue, triage |
| CT aortogram | Very high | Yes | Rupture, dissection, thrombus, branch involvement | Yes | IV iodinated | Primary diagnostic + pre-op planning [2][6][11] |
| TTE | Moderate (root/ascending only) | Yes (for root) | AR, tamponade | None | None | Root/ascending assessment, AR quantification |
| TEE | High (except blind spot at distal ascending) | Yes | Dissection flap, AR, tamponade | None | None | Acute aortic syndrome, intraoperative [3][12] |
| MRA | Very high | Yes | Thrombus, branch involvement, wall inflammation | None | ± Gadolinium | Long-term surveillance (no radiation) |
| DSA | High | No (thrombus → false narrowing) | Branch involvement | Yes | Arterial iodinated | Intraoperative/interventional only [2][6] |
| PET-CT | N/A (assesses inflammation, not size) | No | Aortitis activity | Yes | FDG | Inflammatory aortitis, mycotic aneurysm |
Key Diagnostic Principles to Remember:
- TAA is an imaging diagnosis — no blood test or clinical sign alone confirms it.
- CT aortogram is the primary investigation for diagnosis, acute assessment, and pre-operative planning.
- TTE for root/ascending; TEE for acute aortic syndrome — echo is complementary, not sufficient alone for full aortic assessment.
- MRA is preferred for long-term surveillance in young patients (no radiation).
- DSA should NOT be used to measure aneurysm size (intramural thrombus causes underestimation).
- Always measure the maximum external diameter perpendicular to the long axis.
- Determine the aetiology — this changes surgical thresholds (e.g., 4.5 cm in Marfan vs. 5.5 cm in degenerative).
- Pre-operative cardiac assessment is critical — MI is the leading cause of operative mortality [7].
High Yield Summary
- TAA diagnosis = imaging diagnosis: ≥50% dilatation of normal aortic diameter, confirmed on CT aortogram, echo, or MRA [1][2].
- CXR clues: widened mediastinum, abnormal aortic knuckle, tracheal deviation, wall calcification — but low sensitivity; always confirm with cross-sectional imaging.
- CT aortogram: First-line for diagnosis and pre-op planning. Shows diameter, thrombus, rupture (contrast extravasation), dissection (intimal flap + true/false lumen) [2][6][11].
- TTE: Best for aortic root, proximal ascending, and aortic valve — cannot see distal ascending, arch, or descending [12].
- TEE: More sensitive than TTE; preferred for acute aortic syndrome — can see intimal flap, pericardial effusion, AR [3][12]. Has a "blind spot" at distal ascending/proximal arch.
- MRA: No radiation, ideal for lifelong surveillance in young patients (Marfan, BAV). Less suitable in acute emergencies (slower, equipment incompatibility) [12].
- DSA: NOT for diagnosis (thrombus → false narrowing). Used only intraoperatively for endovascular intervention [2][6].
- Bloods: Troponin (rule out MI), lactate (ischaemia/shock), ESR/CRP (aortitis), blood cultures (mycotic), syphilis serology, genetic testing as indicated [3][5].
- Pre-op essentials: Bloods, ECG, CXR, cardiac assessment — MI is the leading cause of operative mortality [7].
- Surveillance protocol: Imaging at 6 months after diagnosis → annually if stable → more frequent if growth > 0.5 cm/year. Serial imaging at 3, 6, 12 months post-dissection repair [2].
Active Recall - Diagnosis of Thoracic Aortic Aneurysm
References
[1] Senior notes: Maksim Surgery Notes.pdf (Ch 7.1, Aneurysm / AAA) [2] Senior notes: Ryan Ho Cardiology.pdf (Section 4.5.2, Aortic Aneurysms) [3] Senior notes: Maksim Medicine Notes.pdf (Section 1.4, Aortic dissection; Section 1.2, Investigations) [5] Senior notes: Ryan Ho Rheumatology.pdf (Section 3.6.1, GCA and PMR; Section 3.6.2, Takayasu Arteritis) [6] Senior notes: Ryan Ho Radiology.pdf (Acute Traumatic Aortic Injury) [7] Lecture slides: GC 199. Pulsating abdominal mass aortic aneurysm.pdf (p10, p17, p29) [11] Senior notes: Ryan Ho Diagnostic Radiology.pdf (CT Angiography, p43) [12] Senior notes: Ryan Ho Cardiology.pdf (Section 4.5.1, Aortic Dissection — footnotes 201, 202 on TEE vs TTE and CTA vs MRI)
Management of Thoracic Aortic Aneurysm
The management of TAA follows a logical framework: you must decide when to intervene and how to intervene, based on the balance between the risk of rupture (which is fatal) and the risk of the operation (which is significant). This is the same first-principles reasoning used for AAA, just with different thresholds and surgical techniques because of the unique anatomy of the thoracic aorta.
Let me walk you through this systematically.
The core decision in TAA management is balancing the risk of rupture against the risk of operation [7].
| Scenario | Mortality |
|---|---|
| Intact TAA elective repair | ~3–5% (open), ~2–3% (TEVAR) |
| Ruptured TAA repair | > 50% |
| Unoperated rupture | ~100% [7] |
Therefore, the logic is:
- If the aneurysm is small and the annual rupture risk is low → the risk of surgery outweighs the benefit → conservative management with surveillance.
- If the aneurysm is large or growing rapidly → the annual rupture risk exceeds the operative risk → surgical intervention is indicated.
- If the patient is symptomatic (pain, compression) → symptoms indicate impending rupture or complication → urgent intervention regardless of size.
- If the aneurysm has ruptured → emergency intervention is mandatory.
Why Laplace's Law Drives Management Decisions
Recall: Wall Tension = (Pressure × Radius) / (2 × Wall Thickness). As the aorta dilates, wall tension increases exponentially — meaning larger aneurysms grow faster and rupture more readily. This is why there is a size threshold above which intervention is recommended: the natural history curve "crosses over" the surgical risk curve at that point.
A. Conservative Management — Medical Therapy and Surveillance
This applies to asymptomatic TAA below surgical threshold. The goals are to slow aneurysm growth and reduce rupture risk by modifying the factors in Laplace's law — specifically, reducing pressure (blood pressure) and dP/dt (rate of pressure rise, i.e., the force of cardiac contraction).
| Agent | Rationale | Target |
|---|---|---|
| β-Blockers (e.g., labetalol, atenolol, metoprolol, bisoprolol) | ↓HR → ↓dP/dt (the force and rate of aortic wall stress per cardiac cycle). Also ↓BP → ↓Pressure term in Laplace's law. First-line antihypertensive in TAA | SBP < 120 mmHg, HR < 60–70 bpm [3][2] |
| ARBs (e.g., losartan, irbesartan) | Specific benefit in Marfan syndrome — losartan inhibits TGF-β signalling (the pathological driver in Marfan aortopathy). May be added to β-blockers. 2022 ACC/AHA guidelines recommend losartan in Marfan patients | Additive BP reduction; TGF-β inhibition |
| ACE inhibitors | Alternative if ARB not tolerated. Also reduces wall stress | BP control |
| Non-dihydropyridine CCBs (diltiazem, verapamil) | If β-blockers are contraindicated (e.g., severe asthma). ↓HR + ↓contractility similar to β-blockers [3] | Rate + BP control |
Why β-Blockers Are First-Line
β-blockers don't just lower blood pressure — they specifically reduce the rate of pressure rise (dP/dt) in the aorta during systole. This is the "aortic impulse" — the shearing force that drives aneurysm expansion and precipitates dissection. This is why they are superior to pure vasodilators (which lower BP but may cause reflex tachycardia, paradoxically increasing dP/dt). Hydralazine is contraindicated in aortic disease because it causes reflex tachycardia and increases aortic wall shear stress [3].
| Intervention | Why |
|---|---|
| Smoking cessation | Smoking accelerates MMP activity, elastin degradation, and aortic wall weakening. Smoking cessation is the single most impactful modifiable risk factor |
| Statin therapy | Reduces atherosclerotic progression (relevant for descending TAA). May also have anti-inflammatory and MMP-inhibitory effects (pleiotropic benefits). Used regardless of lipid levels for overall cardiovascular protection [1] |
| Moderate exercise | Encouraged, but avoid heavy isometric exercise (weightlifting, straining) — Valsalva manoeuvre causes acute spikes in aortic pressure → ↑rupture/dissection risk. Aerobic exercise at moderate intensity is safe and beneficial |
| Avoid stimulants | Cocaine, amphetamines → acute ↑BP → ↑wall stress → dissection risk [3] |
The purpose is to track aneurysm growth and identify when the surgical threshold is reached.
| Protocol | Details |
|---|---|
| Initial diagnosis | CT aortogram or echo (for root/ascending) to establish baseline diameter |
| First follow-up | 6 months after diagnosis — to calculate initial growth rate |
| Stable, small aneurysm | Annually (CTA or MRA). MRA preferred for young patients to minimise radiation |
| Larger aneurysm approaching threshold | Every 6 months |
| Rapid growth (> 0.5 cm/year) | Indication for surgery regardless of absolute size [1] |
| Post-operative | Serial imaging at 3, 6, 12 months then annually — to detect endoleak, recurrence, pseudoaneurysm [2] |
B. Surgical Indications — When to Operate
This is critical exam material. The thresholds differ by aetiology because the underlying wall pathology varies.
| Condition | Ascending Aorta Threshold | Descending Aorta Threshold |
|---|---|---|
| Degenerative (no genetic/syndromic cause) | ≥5.5 cm | ≥5.5–6.0 cm |
| Bicuspid aortic valve | ≥5.0–5.5 cm (lower if additional risk factors: family history of dissection, rapid growth, coarctation) | N/A (ascending disease predominates) |
| Marfan syndrome | ≥5.0 cm (or ≥4.5 cm if family history of dissection or rapid growth > 0.5 cm/year) | ≥5.0–5.5 cm |
| Loeys-Dietz syndrome | ≥4.0–4.2 cm by TEE (or ≥4.4–4.6 cm by CTA — there is a slight overestimation by CT) | Earlier threshold due to aggressive course |
| Ehlers-Danlos type IV | Individual assessment — surgery itself carries higher risk due to tissue fragility; often manage conservatively unless imminent rupture | Individual assessment |
| Turner syndrome | Aortic size index (ASI) > 2.5 cm/m² — use BSA-indexed diameter because these patients are small | — |
| Any aetiology | If undergoing cardiac surgery for another reason (e.g., AVR for BAV) → lower threshold ≥4.5 cm (opportunistic repair) | — |
| Indication | Reasoning |
|---|---|
| Symptomatic TAA (pain, compression) | Any symptom indicates impending rupture — urgent surgery [7][2] |
| Rapidly expanding (> 0.5 cm/year or > 1 cm/year) | Growth rate exceeds the expected natural history → wall is failing faster than expected [1] |
| Associated with significant aortic regurgitation | AR causes LV volume overload → progressive LV dysfunction → irreversible if delayed. Combined aortic root replacement + valve repair/replacement indicated |
| Ruptured TAA | Emergency — surgical emergency [7] |
| Concomitant aortic dissection | Type A: ALL require emergency surgery. Type B: surgery if complicated [2][3] |
| Mycotic aneurysm | Infection-driven → rapid expansion and high rupture risk. Requires resection + extra-anatomical bypass + prolonged antibiotics |
Exam Tip: Surgical Indications Summary
The indications for surgical repair of TAA follow the same principles as AAA but with different size thresholds:
- Size ≥5.5 cm for degenerative ascending TAA (lower for genetic causes)
- Rapidly expanding > 0.5 cm/year
- Symptomatic (any symptom = urgent)
- Ruptured = emergency
- Significant AR with root aneurysm
- Opportunistic if undergoing cardiac surgery for other reason (threshold ≥4.5 cm)
C. Surgical Modalities — How to Operate
The choice depends on the segment involved and the patient's anatomy and fitness.
1. Open Surgical Repair
Open repair remains the gold standard for the ascending aorta and aortic arch, where endovascular options are limited or technically demanding.
| Feature | Detail |
|---|---|
| Approach | Median sternotomy. Requires cardiopulmonary bypass (CPB) with aortic cross-clamping |
| Procedure | Excise the aneurysmal segment → replace with a synthetic interposition graft (Dacron or PTFE tube graft) → suture proximal and distal anastomoses |
| Aortic valve involvement | If the aortic valve is competent and the root is not dilated → simple supracoronary ascending replacement (spare the valve) |
| If aortic root dilated with AR → need a composite graft procedure (see below) |
The Bentall procedure is the classic operation for aortic root aneurysm with aortic regurgitation [2].
| Feature | Detail |
|---|---|
| What it replaces | Aortic valve, aortic root (sinuses of Valsalva), and ascending aorta — all replaced as a single unit [2] |
| Technique | A composite graft = mechanical (or bioprosthetic) aortic valve pre-sewn into the proximal end of a Dacron tube graft. The coronary ostia are reimplanted into the side of the graft (button technique — Cabrol modification) |
| Indications | Marfan syndrome with root dilatation, annuloaortic ectasia, degenerative root aneurysm with AR, Type A dissection with root involvement [2] |
| Key consideration | Mechanical valve → lifelong anticoagulation (warfarin). Bioprosthetic valve → avoids anticoagulation but limited durability (10–20 years) |
| Feature | Detail |
|---|---|
| Concept | Replace the root and ascending aorta but preserve the native aortic valve by reimplanting or remodelling it inside the graft |
| David procedure (reimplantation) | Native valve resuspended inside the graft — better long-term valve competence |
| Yacoub procedure (remodelling) | Sinus segments replaced, valve left in situ with neo-sinuses created |
| Advantage | Avoids anticoagulation (no prosthetic valve), preserves native valve function |
| Indication | Young patients (Marfan, BAV) with good native valve leaflets but dilated root |
This is the most technically challenging thoracic aortic operation.
| Feature | Detail |
|---|---|
| Challenge | The arch supplies the brain via the great vessels → must maintain cerebral perfusion during surgery |
| Technique | Requires deep hypothermic circulatory arrest (DHCA) — patient cooled to 18–20°C, circulation stopped, arch replaced with a graft, and great vessels reimplanted (as "island" or individual buttons). Brain protected by antegrade or retrograde cerebral perfusion |
| Complications | Stroke (5–10%), prolonged ICU stay, coagulopathy from hypothermia |
| Feature | Detail |
|---|---|
| Approach | Left posterolateral thoracotomy |
| Technique | Aortic cross-clamping above and below the aneurysm → excise and replace with interposition graft. May use left heart bypass (femoral vein → centrifugal pump → femoral artery) to maintain distal perfusion during clamping |
| Key risk | Spinal cord ischaemia → paraplegia. The artery of Adamkiewicz (major radiculomedullary artery, usually T9–T12) supplies the anterior spinal artery. Cross-clamping above its origin → spinal cord infarction [1][7] |
| Mitigation | CSF drainage (↓CSF pressure → ↑spinal perfusion pressure), reimplantation of intercostal arteries, distal aortic perfusion, hypothermia, neuromonitoring (somatosensory/motor evoked potentials) |
This is the most complex aortic operation [7].
| Feature | Detail |
|---|---|
| Challenges | High aortic clamp → proximal hypertension; critical ischaemic time for visceral/renal organs; spinal ischaemia risk [7] |
| Technique | Thoracoabdominal incision. Sequential clamping. Graft replacement. Bypass and reimplant visceral arteries (coeliac trunk, SMA, renal arteries) as buttons or individual grafts [7] |
| Mortality | 5–15% depending on extent (Crawford Type II has the highest risk) |
2. Endovascular Repair — TEVAR (Thoracic Endovascular Aortic Repair)
TEVAR = "Thoracic Endovascular Aortic Repair" — the thoracic equivalent of EVAR for AAA [7][13].
| Feature | Detail |
|---|---|
| Concept | A covered stent graft is deployed via the femoral artery, navigated under fluoroscopic guidance to the thoracic aorta, and expanded to line the aneurysm from within — excluding it from the circulation |
| Best suited for | Descending thoracic aorta aneurysms [7] — this is where TEVAR excels because the anatomy is relatively straightforward (a tube) |
| Advantages over open | Lower perioperative morbidity and mortality (~2–3% vs. 5–10% for open). No thoracotomy → less pain, shorter ICU stay, faster recovery. ↓Risk of bleeding, tissue damage (no need to clamp aorta) [13]. Avoids general anaesthesia in some cases (can be done under regional/local) |
| Disadvantages | Requires suitable landing zone anatomy (adequate length of normal aorta proximal and distal to the aneurysm). Long-term durability uncertain (endoleak, stent migration). Lifelong surveillance required. Cannot address the aortic root or ascending aorta (currently) |
| Contraindications | Ascending aortic aneurysm (no landing zone — would occlude coronaries or great vessels). Inadequate landing zones. Severe iliac/femoral disease preventing access. Connective tissue diseases (relative — tissue fragility may compromise seal) |
| Requirement | Why |
|---|---|
| Proximal landing zone ≥2 cm of normal aorta | Ensures adequate seal to prevent Type I endoleak |
| Distal landing zone ≥2 cm of normal aorta | Same principle |
| Access vessels (iliac/femoral) ≥7 mm | Stent graft delivery system must pass through |
| Minimal tortuosity and calcification | Prevents graft malposition and poor seal |
The same endoleak classification used for EVAR applies to TEVAR [1]:
| Type | Description | Clinical Significance | Management |
|---|---|---|---|
| I | Seal failure at proximal (Ia) or distal (Ib) end | Direct flow into aneurysm sac → requires re-intervention | Repeat endovascular intervention, extension cuff, or open conversion |
| II | Backflow from side branches (intercostal arteries, bronchial arteries) — most common type | Usually benign. Monitor for sac expansion | Close observation → embolisation if sac expanding |
| III | Graft defect (fabric tear, modular disconnection) | Direct flow → requires re-intervention | Repair defect / bridge across |
| IV | Graft porosity | Self-limiting | Observe |
| V | Endotension (sac expansion without visible leak) | Uncertain significance | Observe or consider re-intervention |
Types I and III have continuous direct flow into the aneurysm sac → require re-operation! [1]
For aneurysms involving the aortic arch or thoracoabdominal aorta, standard TEVAR alone is insufficient because deploying a stent across great vessels or visceral arteries would occlude them. Solutions include:
| Technique | Concept |
|---|---|
| Hybrid repair | Open surgical debranching of arch vessels (bypass from ascending aorta to brachiocephalic + left carotid + left subclavian) followed by TEVAR of the arch. Avoids DHCA |
| Branched stent grafts | Custom-made stent graft with side branches that extend into great vessels or visceral arteries [7] |
| Fenestrated grafts | Stent graft with holes (fenestrations) aligned with branch vessel ostia, allowing continued perfusion [7] |
| Chimney / snorkel grafts | Parallel stents placed in branch vessels alongside the main graft to maintain branch perfusion |
D. Management of Specific Scenarios
| Step | Detail |
|---|---|
| ABC resuscitation | High-flow O2, two large-bore IV access, urgent crossmatch (≥6 units packed RBCs) |
| Permissive hypotension | SBP target 80–100 mmHg — higher pressures worsen bleeding through the rupture site [1] |
| Massive transfusion protocol | Packed cells : FFP : platelets = 1:1:1 (e.g., 6 units each) [1] |
| Immediate surgery | If haemodynamically unstable → operating theatre immediately without CTA (no time). If briefly stabilisable → rapid CTA to assess TEVAR suitability |
| Surgical options | Open repair or emergency TEVAR (if descending TAA with suitable anatomy and available expertise) |
| Prognosis | Operative mortality > 50%. Unoperated mortality ~100% [7] |
This is managed as acute aortic syndrome — the dissection takes priority:
| Type | Management |
|---|---|
| Type A dissection (involves ascending aorta) | ALL require emergency open repair — excise intimal tear, obliterate entry site, place interposition synthetic aortic graft ± repair/replacement of aortic valve → Bentall procedure if AV, root, ascending aorta all involved [2][3] |
| Type B uncomplicated | Medical management: anti-impulse therapy — SBP 100–120 mmHg, HR < 60 bpm [2][3]. 1st line: β-blocker (labetalol, esmolol) or non-dihydropyridine CCB (diltiazem, verapamil) [3]. 2nd line: add sodium nitroprusside (only with β-blocker pre-treatment to prevent reflex tachycardia) [3] |
| Type B complicated (malperfusion, rupture, rapid expansion, retrograde dissection, Marfan) | TEVAR (endovascular stent-grafting) preferred; open repair if anatomy complex [2] |
| Post-dissection follow-up | Lifelong antihypertensive therapy to target BP < 120/80 mmHg [2]. Serial imaging (MRA/CTA at 3, 6, 12 months) to detect recurrence, aneurysm formation, or endoleak [2] |
Emergency pericardiocentesis if cardiac tamponade (from Type A dissection rupturing into pericardium) [2]
Anti-Impulse Therapy — Explained from First Principles
"Anti-impulse" therapy means reducing the aortic wall stress per heartbeat (dP/dt) — the "impulse" the blood exerts on the aortic wall with each systolic contraction. This requires:
- ↓HR (fewer impulses per minute) — β-blocker
- ↓Contractility (less forceful impulse) — β-blocker
- ↓BP (lower pressure term) — β-blocker + vasodilator if needed
Labetalol is ideal because it is both an α1-blocker (vasodilation → ↓BP) and a non-selective β-blocker (↓HR + ↓contractility) [3]. Hydralazine is contraindicated because it causes reflex tachycardia (increases dP/dt — exactly what you don't want) [3].
| Step | Detail |
|---|---|
| Antibiotics | Prolonged IV antibiotics (≥6 weeks) targeting the causative organism — empiric coverage for Salmonella + S. aureus until cultures return |
| Surgery | Resection of infected aortic segment + extra-anatomical bypass (route the bypass graft away from the infected field). In situ graft with rifampicin-soaked Dacron or cryopreserved homograft is an alternative |
| Prognosis | Poor — high operative mortality and risk of recurrent infection |
| Step | Detail |
|---|---|
| Medical | Immunosuppression to control the underlying aortitis — prevents further wall destruction |
| GCA: urgent high-dose systemic corticosteroids (prednisolone 1–2 mg/kg/day) → slow taper over 1–2 years. Steroid-sparing: tocilizumab (anti-IL-6), methotrexate [5] | |
| Takayasu: high-dose corticosteroids 1 mg/kg/day → taper. Steroid-sparing: methotrexate or azathioprine [5] | |
| Surgical | If aneurysm reaches surgical threshold → repair as per standard TAA. Ideally operate when aortitis is in remission (quiescent phase) — operating during active inflammation → higher risk of anastomotic pseudoaneurysm |
The major operative mortality in aortic surgery is myocardial infarction [7] — because these patients almost always have coexisting coronary artery disease, and the surgery involves major haemodynamic stress.
| Step | Detail |
|---|---|
| General: blood tests, ECG, CXR [7] | Baseline assessment |
| Cardiac assessment / intervention [7] | Stress testing (exercise or pharmacological). Coronary angiography if positive. PCI/CABG if significant CAD → then proceed with aortic repair |
| Preparation: monitors, blood [7] | Arterial line, central venous access, PA catheter (if needed). Type and screen, crossmatch ≥6 units packed RBCs [2] |
| Pulmonary function tests | Thoracotomy significantly impairs respiratory function post-op; identify high-risk patients |
| Renal function | Baseline Cr/eGFR; plan renal protection during cross-clamping |
| Thromboprophylaxis | IV heparin during surgery (prevent graft thrombosis and distal embolisation) |
| Aspect | Detail |
|---|---|
| ICU care | Haemodynamic monitoring (arterial line, CVP), chest drain management, ventilator weaning, urine output monitoring |
| BP control | Lifelong antihypertensive therapy targeting BP < 120/80 mmHg — reduces stress on graft anastomoses and remaining native aorta [2] |
| Surveillance imaging | CTA or MRA at 3, 6, 12 months post-op, then annually [2]. After TEVAR: lifelong surveillance for endoleak, stent migration, sac expansion |
| Antiplatelet | Aspirin for secondary prevention of cardiovascular events [1] |
| Anticoagulation | Required if mechanical aortic valve (Bentall with mechanical valve) — warfarin, target INR 2.0–3.0 |
| Genetic counselling | If genetic/syndromic cause identified → screen first-degree relatives (echo/CTA). Genetic testing for at-risk family members |
| Activity | Avoid heavy isometric exercise, competitive contact sports. Moderate aerobic exercise encouraged |
| Segment | Preferred Surgical Approach | Why |
|---|---|---|
| Aortic root | Open: Bentall procedure (composite valve-graft) or valve-sparing root replacement [2] | TEVAR cannot access the root without occluding coronaries. Root pathology almost always involves the valve |
| Ascending aorta | Open: ascending aorta replacement ± Bentall [2] | TEVAR not feasible — no proximal landing zone without occluding coronaries/great vessels |
| Aortic arch | Open: total arch replacement with DHCA or hybrid debranching + TEVAR or branched TEVAR [7] | Most complex segment; involves cerebral perfusion. Hybrid approaches increasingly used to avoid DHCA |
| Descending thoracic aorta | TEVAR preferred if anatomy suitable [7][13] | Lower morbidity/mortality than open thoracotomy. First-line in many Western centres [13] |
| Thoracoabdominal | Open repair with visceral reimplantation or branched/fenestrated TEVAR [7] | Must maintain visceral/renal perfusion. High aortic clamp, critical ischaemic time, spinal ischaemia risk [7] |
High-Yield Comparison: Open Repair vs. TEVAR for Descending TAA
| Feature | Open Repair | TEVAR |
|---|---|---|
| 30-day mortality | 5–10% | 2–3% |
| Approach | Left thoracotomy, aortic cross-clamp | Femoral arteriotomy, fluoroscopic guidance |
| Anaesthesia | General (often with one-lung ventilation) | General or regional |
| Spinal cord ischaemia | 5–10% | 3–5% (still a risk — stent covers intercostals) |
| Long-term durability | Excellent — graft lasts a lifetime | Uncertain — endoleak, migration, re-intervention needed |
| Surveillance | Minimal | Lifelong (CT at 1, 6, 12 months then annually) |
| Re-intervention rate | Low | Higher (endoleak, graft-related complications) |
| Overall long-term mortality | Similar | Similar |
| Best for | Young, fit patients with long life expectancy; complex anatomy not suitable for TEVAR | Older patients, comorbid patients, favourable anatomy |
High Yield Summary
- Fundamental principle: Balance risk of rupture vs. risk of operation [7]. Intact TAA repair mortality 3–5%; ruptured TAA repair mortality > 50%; unoperated rupture ~100%.
- Conservative management: β-blockers first-line (↓dP/dt + ↓BP). Hydralazine contraindicated (reflex tachycardia). CV risk factor modification. Surveillance imaging 6-monthly → annually.
- Surgical thresholds: ≥5.5 cm for degenerative ascending TAA; ≥5.0 cm for Marfan; ≥4.0–4.2 cm for Loeys-Dietz. Also operate for: any symptoms (impending rupture), rapid growth > 0.5 cm/year, rupture, significant AR, opportunistic if undergoing cardiac surgery.
- Ascending aorta / root: Open repair only — Bentall procedure (composite valve-graft) or valve-sparing root replacement [2]. TEVAR not feasible here.
- Descending thoracic aorta: TEVAR preferred if suitable anatomy [7][13]. Lower morbidity but requires lifelong surveillance for endoleak.
- Aortic arch: Most complex — open arch repair (DHCA) or hybrid debranching + TEVAR or branched TEVAR [7].
- Thoracoabdominal: High aortic clamp, proximal hypertension, critical ischaemic time, spinal ischaemia risk. Bypass and reimplant visceral arteries [7].
- Type A dissection: ALL require emergency open repair. Type B uncomplicated: anti-impulse therapy. Type B complicated: TEVAR [2][3].
- Anti-impulse therapy: Labetalol (α1 + non-selective β-blocker). Target SBP 100–120, HR < 60. Never use hydralazine [3].
- Pre-op: Blood tests, ECG, CXR. Cardiac assessment/intervention. Monitors, blood. Major operative mortality = myocardial infarction [7].
- Endoleak Types I and III have direct flow into the aneurysm sac → require re-operation! [1]
- Post-op: Lifelong BP control < 120/80. Serial imaging at 3, 6, 12 months then annually [2].
Active Recall - Management of Thoracic Aortic Aneurysm
References
[1] Senior notes: Maksim Surgery Notes.pdf (Ch 7.1, Aneurysm / AAA — management, endoleak classification) [2] Senior notes: Ryan Ho Cardiology.pdf (Section 4.5.1, Aortic Dissection — management; Section 4.5.2, Aortic Aneurysms — surgical management) [3] Senior notes: Maksim Medicine Notes.pdf (Section 1.4, Aortic dissection — anti-impulse therapy, labetalol MOA, hydralazine CI) [5] Senior notes: Ryan Ho Rheumatology.pdf (Section 3.6.1, GCA treatment; Section 3.6.2, Takayasu treatment) [6] Senior notes: Ryan Ho Radiology.pdf (Acute Traumatic Aortic Injury — TEVAR, DSA) [7] Lecture slides: GC 199. Pulsating abdominal mass aortic aneurysm.pdf (p10 — operative mortality, pre-op; p17 — thoracoabdominal challenges; p29 — endovascular repair thoracic aneurysms) [13] Senior notes: Ryan Ho Diagnostic Radiology.pdf (p85, Stent graft for aortic aneurysms — first-line in many Western countries, advantages over open)
Complications of Thoracic Aortic Aneurysm
Complications of TAA can be divided into two broad categories:
- Complications of the aneurysm itself (natural history — what happens if you don't treat it)
- Complications of surgical repair (what happens when you do treat it)
Both categories are crucial for exams. Let me walk through each systematically, explaining the pathophysiology from first principles.
A. Complications of the Aneurysm Itself
These are the complications of aneurysms as a disease entity [7]:
Rupture, Thrombosis, Embolism, Infection, Pressure effects [7]
Let's go through each.
Why does rupture happen? Laplace's law: as the aneurysm grows, wall tension increases exponentially while wall thickness decreases → eventually the wall stress exceeds the tensile strength of the remaining tissue → transmural tear → catastrophic haemorrhage.
| Feature | Ascending Aorta Rupture | Descending Aorta Rupture |
|---|---|---|
| Direction of rupture | Into the pericardium (ascending aorta is intrapericardial) | Into the left pleural space (descending aorta abuts the left pleura) or mediastinum |
| Immediate consequence | Cardiac tamponade → obstructive shock → PEA arrest | Massive left haemothorax → hypovolaemic shock |
| Presentation | Sudden chest pain → rapid cardiovascular collapse → cardiac arrest. Beck's triad if tamponade (hypotension, muffled heart sounds, JVP elevation) | Sudden severe back/chest pain → haemodynamic instability → shock |
| Mortality | Ruptured TAA repair mortality > 50%. Unoperated rupture mortality ~100% [7] | Same |
Why is the ascending aorta rupture into the pericardium so lethal? Because the pericardium is a relatively inelastic fibrous sac. Even a small volume of blood (150–200 mL) filling rapidly compresses the heart → ↓ventricular filling → ↓cardiac output → shock → death within minutes. This is far more rapidly fatal than left haemothorax, where the pleural space can accommodate litres of blood before cardiac compromise.
Rupture into other structures (rare but high-yield):
| Fistula | Mechanism | Presentation |
|---|---|---|
| Aorto-oesophageal fistula | Descending TAA erodes posteriorly into the oesophagus | Massive haematemesis (often preceded by a "herald bleed" — a small initial bleed followed hours-days later by exsanguinating haemorrhage). Classically described as Chiari triad: mid-thoracic pain → herald haematemesis → exsanguination |
| Aorto-bronchial fistula | TAA erodes into adjacent bronchial tree (left main bronchus or left lower lobe bronchus) | Massive haemoptysis |
| Aortoenteric fistula | Occurs primarily after open AAA/TAA graft repair — graft erodes into adjacent bowel (classically D3/D4 of duodenum for AAA grafts; oesophagus or jejunum for thoracoabdominal grafts) | Classic triad: UGIB + fever + abdominal pain [1]. Must be considered in any patient with prior aortic graft repair presenting with GI bleeding — aortoenteric fistula until proven otherwise [1] |
A pre-existing TAA is one of the strongest risk factors for aortic dissection because:
- The aortic wall is already weakened (medial degeneration)
- The aorta is already dilated → ↑wall stress → the intima is under more tension → more likely to tear
Complications of dissection arising from TAA [3][2]:
| Complication | Mechanism | Presentation |
|---|---|---|
| MI | Dissection flap extends retrogradely into the aortic root → occludes a coronary ostium (usually the right coronary) | Acute chest pain + ST elevation (usually inferior leads) |
| Ischaemic stroke | Dissection extends into a carotid artery → occludes cerebral blood flow | Focal neurological deficit, hemiplegia, aphasia |
| Acute aortic regurgitation → APO | Dissection disrupts the aortic root architecture → aortic valve commissures lose support → acute severe AR → LV cannot compensate (no time for dilatation) → acute pulmonary oedema [3] | Sudden severe dyspnoea, pink frothy sputum, new early diastolic murmur |
| Cardiac tamponade | Type A dissection ruptures through the adventitia into the pericardium | Beck's triad, PEA arrest |
| Mesenteric ischaemia | Dissection occludes the coeliac trunk or SMA | Severe abdominal pain out of proportion to examination, ↑lactate, bloody diarrhoea |
| AKI | Dissection occludes renal arteries | Oliguria/anuria, ↑creatinine |
| Limb ischaemia | Dissection occludes iliac or subclavian arteries | Acute limb ischaemia (6 P's) |
| Spinal cord ischaemia → paraplegia | Dissection occludes intercostal arteries supplying the artery of Adamkiewicz | Acute paraplegia, loss of bladder/bowel control |
Why does thrombus form in an aneurysm? Virchow's triad:
- Stasis — the aneurysmal sac creates turbulent, slow-moving blood (especially at the periphery of the sac)
- Endothelial injury — the diseased aortic intima provides a prothrombotic surface
- Hypercoagulability — chronic inflammation activates coagulation pathways
This mural thrombus can:
- Embolise distally → depending on the segment:
- Ascending/arch TAA → stroke, TIA (cerebral embolism) or upper limb ischaemia
- Descending TAA → blue toe syndrome / trash foot (microembolisation to digital arteries), mesenteric ischaemia, renal infarction, lower limb ischaemia
- Grow and occlude → rare in the thoracic aorta due to high flow, but can narrow the lumen in chronic TAA
Blue toe syndrome / trash foot: Microemboli of cholesterol crystals and thrombus lodge in small digital arteries → ischaemic, painful, cyanotic toes with palpable pedal pulses (because the large arteries are patent — it's the small vessels that are blocked). This paradox of "blue toes with good pulses" is the hallmark [1][7].
An existing TAA can become secondarily infected (or may have been infectious from the outset — mycotic aneurysm). Infection weakens the wall further → accelerated expansion → high rupture risk.
- Organisms: non-typhoid Salmonella (especially in Asia/Hong Kong), S. aureus, Streptococcus, TB (rare, contiguous from vertebral TB)
- Presentation: fever, constitutional symptoms, back/chest pain, elevated inflammatory markers, positive blood cultures
- Management: prolonged IV antibiotics + surgical resection (in situ graft or extra-anatomical bypass)
These were covered in detail in the Clinical Features section but are formally classified as complications of the aneurysm [2][7]:
| Structure Compressed | Complication | Segment |
|---|---|---|
| Left recurrent laryngeal nerve | Hoarseness (Ortner syndrome / cardiovocal syndrome) | Aortic arch / proximal descending |
| Oesophagus | Dysphagia (dysphagia aortica) | Arch / descending |
| Trachea / left main bronchus | Stridor, cough, dyspnoea | Arch / ascending |
| Superior vena cava | SVC obstruction (rare) | Ascending / arch |
| Vertebral bodies / sternum / ribs | Bone erosion, visible pulsatile chest wall mass | Descending (vertebral) / ascending (sternal) |
| Pulmonary artery | Pulmonary stenosis (very rare) | Ascending |
This is specifically a complication of aortic root / ascending aorta aneurysm. The mechanism:
- Root dilatation → aortic annulus stretches → valve leaflets cannot coapt → central AR jet
- Chronic AR → LV volume overload → compensatory LV dilatation → eventually decompensation (↓LVEF, ↑LV end-diastolic pressure → LV failure → dyspnoea, angina)
- Acute AR (if dissection → sudden annular disruption) → LV cannot dilate acutely → acute pulmonary oedema (surgical emergency) [2]
B. Complications of Surgical Repair
These apply to both open repair and TEVAR (endovascular repair), with some complications unique to each modality.
Open Repair Complications
| Complication | Mechanism | Incidence / Notes |
|---|---|---|
| Myocardial infarction | Stress of clamping/declamping → massive haemodynamic shifts (↑afterload during clamp → ↑myocardial O₂ demand; ↓afterload upon unclamping → hypotension). Major operative mortality = MI [7] | Leading cause of perioperative death [7]. This is why pre-operative cardiac assessment is mandatory |
| Haemorrhage | Large suture lines in diseased tissue, coagulopathy from CPB/hypothermia, heparin use. Often ≥1–2 litres [2] | Common; requires meticulous surgical technique and massive transfusion readiness |
| Renal failure | Renal artery clamping/embolism → renal ischaemia. Even infrarenal clamping reduces renal blood flow by ~60%. More common with suprarenal repair [1][2] | Monitor urine output closely post-op; may require temporary dialysis |
| Bowel ischaemia | Ligation or embolisation of mesenteric vessels. IMA occlusion → ischaemic colitis (sigmoid colon watershed). SMA involvement → small bowel infarction | More commonly affects colon (IMA territory) than small bowel (SMA territory) [2]. Present with bloody diarrhoea, abdominal pain, ↑lactate. May require colectomy |
| Paraplegia / spinal cord ischaemia | Ligation of intercostal arteries supplying the artery of Adamkiewicz (major anterior spinal artery feeder, usually T9–T12). Cross-clamping the descending aorta interrupts all intercostal flow temporarily. More common in thoracic/thoracoabdominal aortic repair [1][2][7] | Devastating — presents as weakness, incontinence, sexual dysfunction [1]. Risk: 5–10% for descending/thoracoabdominal repair. Mitigation: CSF drainage, reimplantation of intercostals, hypothermia, distal perfusion, neuromonitoring |
| Trash foot / lower limb ischaemia | Distal embolism of mural thrombus dislodged during surgery, or clamp injury to iliac arteries, or anastomotic kinking [1][7] | Present with mottled, ischaemic foot post-op. Prevention: heparinisation, careful purging before declamping |
| Respiratory failure / ARDS | Thoracotomy → post-op atelectasis and pain → impaired ventilation. CPB → inflammatory response → capillary leak → ARDS [2] | Prolonged ventilation may be needed |
| Iatrogenic injury | Surgical trauma to adjacent structures: ureter, spleen, pancreas, bowel [2] | Related to the extensive dissection required for access |
| Sexual dysfunction / impotence | Damage to retroperitoneal autonomic nerves (hypogastric plexus) during dissection, especially for thoracoabdominal or infrarenal repairs [1][7] | Impotence, retrograde ejaculation. Important to warn patients pre-operatively |
| Complication | Mechanism | Presentation |
|---|---|---|
| Graft infection | Haematogenous seeding or perioperative contamination of the synthetic graft (Dacron/PTFE). Prosthetic material provides a surface for biofilm formation — bacteria adhere and become resistant to antibiotics and immune clearance | Fever, constitutional symptoms, perigraft collection on CT. Devastating complication — requires graft excision + extra-anatomical bypass (or in situ replacement with rifampicin-soaked graft / cryopreserved homograft) + prolonged IV antibiotics |
| Graft thrombosis | Thrombus formation within the graft, especially at anastomotic sites or in low-flow states | Acute limb ischaemia (if aorto-iliac/femoral graft) or visceral ischaemia |
| Aortoenteric fistula | Graft erodes into adjacent bowel (mostly D3/D4 of duodenum for AAA grafts, oesophagus/jejunum for thoracoabdominal grafts). Can occur years after repair [1][7] | Classic triad: UGIB + fever + abdominal pain [1]. Ix: OGD (up to D4), contrast CT. Mx: graft excision + extra-anatomical bypass. Aortoenteric fistula until proven otherwise in any patient with prior aortic graft repair presenting with GI bleeding [1] |
| Anastomotic (pseudo-) aneurysm | Suture line breaks down over time (infection, tissue degeneration, suture failure) → blood leaks through and is contained by connective tissue → pulsatile mass at anastomotic site [1][7] | Pulsatile mass near previous surgical site. Risk of rupture. May require re-operation |
TEVAR (Endovascular) Complications [1][2]
| Complication | Mechanism | Incidence / Notes |
|---|---|---|
| Endoleak (~30%) | Persistent blood flow into the aneurysm sac despite the stent graft [1] — the graft fails to completely exclude the aneurysm. See classification table below | Most important TEVAR-specific complication — the whole point of TEVAR is to exclude the sac; endoleak means failure of this objective |
| Graft migration | Over time, the fixation between the stent graft and the aortic wall loosens (especially if the proximal aortic neck dilates) → graft slides distally → loss of seal → Type Ia endoleak [2] | May require re-intervention (extension cuff or open conversion) |
| Graft thrombosis / limb occlusion | Thrombus within the graft (especially modular limbs) or kinking of the graft | Acute ischaemia of the territory the graft supplies |
| Separation of components | Modular graft has multiple overlapping components → inadequate overlap or shrinking of aneurysm sac over time → components disconnect → Type III endoleak [2] | Requires bridging stent or open conversion |
| Graft infection (0.4–3%) | Same principle as open graft infection — prosthetic material + biofilm [2] | Rare but devastating |
| Type | Description | Direct Flow? | Management |
|---|---|---|---|
| I | Seal failure at proximal (Ia) or distal (Ib) attachment site | Yes — high-pressure | Requires re-intervention (extension cuff, relining, or open conversion) [1] |
| II | Backflow from side branches (intercostal arteries, bronchial arteries) — most common type ("retroleak") | No — low-pressure | Observe; intervene only if sac expanding (embolisation of feeding vessel) [1] |
| III | Mechanical graft disruption (fabric tear, modular dehiscence) | Yes — high-pressure | Requires re-intervention (bridge across defect or relining) [1] |
| IV | Graft porosity (blood seeps through graft material pores) | No | Self-limiting; observe |
| V | Endotension — sac expansion without demonstrable endoleak source | Unknown | Observe or consider re-intervention |
Key principle: Types I and III have continuous direct high-pressure flow into the aneurysm sac → the sac remains pressurised → rupture risk persists → require re-operation! [1]
| Complication | Mechanism |
|---|---|
| Bleeding, haematoma | Arteriotomy site in the femoral artery |
| Pseudoaneurysm | Incomplete repair of arteriotomy → contained pulsatile haematoma at the groin |
| AV fistula | Needle passes through both artery and adjacent vein → abnormal communication |
| Thromboembolism | Catheter manipulation → dislodge atheromatous plaque or thrombus → distal embolisation |
These are similar to open repair because the fundamental issue — covering aortic branch ostia — is common to both approaches:
| Complication | Mechanism |
|---|---|
| Cardiac: MI (1.8–5.3%) | Perioperative myocardial stress (though less than open repair) [2] |
| Respiratory (2.9–3.3%) | Post-operative atelectasis, pneumonia |
| Contrast complications | Contrast-induced nephropathy (0.7–2%), allergic reaction [2] |
| Renal ischaemia (0.7–18%) | Stent graft covering renal artery ostia (especially in thoracoabdominal cases), contrast nephropathy, atheroembolism [2] |
| Intestinal ischaemia | Coverage of mesenteric artery ostia or atheroembolism |
| Lower limb ischaemia | Iliac artery injury from graft delivery system, atheroembolism |
| Pelvic ischaemia | Internal iliac artery coverage or embolisation |
| Spinal cord ischaemia | Coverage of multiple intercostal arteries by the stent graft → loss of blood supply to the artery of Adamkiewicz. Risk is proportional to the length of aorta covered |
| Post-implantation syndrome (13–60%) | Transient flu-like inflammatory syndrome following endograft placement in first 7–10 days. Mechanism unknown → no specific treatment required [2] |
Spinal Cord Ischaemia — A Shared Complication
Both open repair and TEVAR carry risk of spinal cord ischaemia → paraplegia. For TEVAR, the risk increases with:
- Longer coverage length (more intercostals sacrificed)
- Prior or simultaneous infrarenal AAA repair (already lost lumbar arteries)
- Hypotension during/after the procedure
- Left subclavian artery coverage without revascularisation (vertebral artery contributes collateral spinal supply)
Prevention: CSF drainage (lumbar drain → ↓CSF pressure → ↑spinal cord perfusion pressure), maintain MAP > 80 mmHg, staged procedures if possible, prophylactic left subclavian revascularisation.
| Complication | Explanation |
|---|---|
| Aneurysm at other sites | Patients with TAA have a ~20% chance of aneurysms elsewhere (AAA, iliac, femoral, popliteal, cerebral) [1]. Screening recommended |
| Post-dissection aneurysm | After aortic dissection (treated or untreated), the false lumen may progressively dilate → chronic aneurysm → requires late intervention. This is why lifelong imaging surveillance is mandatory [2] |
| Persistent hypertension | Even after successful repair, hypertension often persists (due to arterial remodelling, renal artery involvement, or underlying essential hypertension). Lifelong antihypertensive therapy is required |
| Recurrent aneurysm / progression | The underlying aortopathy (especially in genetic conditions) doesn't go away after surgery — adjacent segments may dilate over time. This is why the entire aorta must be surveilled, not just the repaired segment |
| Heart failure | Chronic AR (if not addressed at surgery) → progressive LV dilatation and failure |
| Endoleak and late rupture after TEVAR | TEVAR does not "cure" the aneurysm — the sac is excluded but still present. Endoleak can develop months-years later → sac re-pressurisation → late rupture. This is why lifelong surveillance with CT is mandatory after TEVAR [1][2] |
| Category | Complication | Key Pathophysiology |
|---|---|---|
| Aneurysm itself | Rupture | Laplace's law → wall stress exceeds tensile strength |
| Dissection | Weakened media + ↑wall stress → intimal tear | |
| Thrombosis and embolism | Virchow's triad in aneurysm sac → mural thrombus → distal embolisation | |
| Infection | Secondary infection of diseased wall → mycotic aneurysm | |
| Pressure effects | Compression of RLN, oesophagus, trachea, SVC, vertebrae | |
| Aortic regurgitation | Root dilatation → annular stretching → leaflet malcoaptation | |
| Open repair — Early | MI | Clamp/declamp haemodynamic stress (leading cause of operative mortality) |
| Haemorrhage | Suture lines, coagulopathy | |
| Renal failure | Renal artery clamping/embolism | |
| Bowel ischaemia | IMA/SMA sacrifice → colonic/small bowel infarction | |
| Paraplegia | Intercostal artery ligation → artery of Adamkiewicz loss | |
| Trash foot | Distal embolism during surgery | |
| Open repair — Late | Graft infection | Biofilm on prosthetic material |
| Aortoenteric fistula | Graft erosion into bowel (D3/D4 or oesophagus) | |
| Anastomotic pseudoaneurysm | Suture line breakdown | |
| TEVAR | Endoleak | Incomplete exclusion of aneurysm sac (Types I–V) |
| Graft migration | Loss of fixation over time | |
| Spinal cord ischaemia | Coverage of intercostal arteries | |
| Post-implantation syndrome | Transient inflammatory response (benign, self-limiting) | |
| Access site complications | Bleeding, pseudoaneurysm, AV fistula at femoral artery |
High Yield Summary
- Complications of aneurysms: Rupture, Thrombosis, Embolism, Infection, Pressure effects [7] — memorise this list.
- Rupture is the most feared complication. Ascending TAA ruptures into the pericardium → tamponade (rapidly fatal). Descending TAA ruptures into the left pleural space → haemothorax. Mortality of unoperated rupture ~100% [7].
- TAA is a major risk factor for aortic dissection → dissection leads to secondary complications: MI, stroke, AR → APO, tamponade, mesenteric ischaemia, AKI, limb ischaemia, paraplegia [3].
- Aorto-oesophageal fistula (massive haematemesis) and aorto-bronchial fistula (massive haemoptysis) are rare but classical complications of descending TAA.
- Aortoenteric fistula after graft repair: classic triad of UGIB + fever + abdominal pain → aortoenteric fistula until proven otherwise [1].
- Leading cause of operative mortality = myocardial infarction (stress of clamping/declamping) [7].
- Paraplegia from artery of Adamkiewicz ischaemia — risk in both open repair and TEVAR for descending/thoracoabdominal aneurysms [1][7].
- Endoleak after TEVAR: Types I and III have direct high-pressure flow → require re-intervention. Type II (most common) is usually observed [1].
- Post-implantation syndrome (13–60%): transient flu-like illness after TEVAR, benign, self-limiting, no specific treatment needed [2].
- Lifelong surveillance is mandatory after any TAA repair — for endoleak (TEVAR), graft complications (open), and progression of disease in remaining native aorta.
Active Recall - Complications of Thoracic Aortic Aneurysm
References
[1] Senior notes: Maksim Surgery Notes.pdf (Ch 7.1, Aneurysm / AAA — complications of open and EVAR, endoleak classification, aortoenteric fistula) [2] Senior notes: Ryan Ho Cardiology.pdf (Section 4.5.2, Aortic Aneurysms — complications of open repair and EVAR; Section 4.5.1, Aortic Dissection — complications) [3] Senior notes: Maksim Medicine Notes.pdf (Section 1.4, Aortic dissection — complications: MI, stroke, tamponade, AR, mesenteric ischaemia) [7] Lecture slides: GC 199. Pulsating abdominal mass aortic aneurysm.pdf (p3 — complications of aneurysms; p15 — early and late operative complications; p29 — thoracic aneurysm rupture)
Coarctation Of The Aorta
Coarctation of the aorta is a congenital narrowing of the aorta, typically occurring near the ductus arteriosus just distal to the left subclavian artery, resulting in upper extremity hypertension and reduced lower extremity perfusion.
Aortitis
Aortitis is inflammation of the aortic wall, which can be caused by infectious agents, large-vessel vasculitides (such as giant cell arteritis or Takayasu arteritis), or autoimmune conditions, potentially leading to aneurysm formation, stenosis, or aortic valve insufficiency.